https://www.healthpressbhutan.com/article/910506952-septerna-to-present-at-bank-of-america-securities-health-care-conference
Septerna to Present at Bank of America Securities Health Care Conference | Health Press Bhutan
bank of america securities
https://www.septerna.com/
Septerna
Septerna is a biotechnology company discovering and advancing novel small molecule medicines targeting G protein-coupled receptors
https://www.itiger.com/news/2627307394
Septerna starts Phase 1 trial of SEP-479 oral hypoparathyroidism drug - Tiger Brokers
Septerna starts Phase 1 trial of SEP-479 oral hypoparathyroidism drug. On Tiger Brokers' website to stay informed on market trends, price movements, and...
https://www.hl.co.uk/shares/shares-search-results/s/septerna-inc-usd0.001
Septerna Inc USD0.001 share price | SEPN
The latest Septerna Inc USD0.001 share price (SEPN). View recent trades and share price information for Septerna Inc USD0.001.
share priceincsepn
https://www.itiger.com/news/2618604323
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631...
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating. On Tiger Brokers' website to stay...